chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash in various parts of the body; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 36-years-old female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Ep7533, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 06Apr2021 at 12:00 pm (age at vaccination was 36 years) as dose 2, single for COVID-19 immunization. The patient's medical history included Caesarean section performed. Concomitant medication included acetaminophen taken for an unspecified indication. The patient previously took NSAIDS and experienced allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 19:00 pm, the patient experienced rash in various parts of the body. No treatment was received for the adverse event. The outcome of event was not resolved.  No follow-up attempts are possible. No further information is expected.
Went to ER after shot that same day nausea, vomit a few times then passed out. Weakness admitted to hosp.
pain all over her stomach; nausea; Patient threw up for 2 days in a row.; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (pain all over her stomach), NAUSEA (nausea) and VOMITING (Patient threw up for 2 days in a row.) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (pain all over her stomach), NAUSEA (nausea) and VOMITING (Patient threw up for 2 days in a row.). At the time of the report, ABDOMINAL PAIN UPPER (pain all over her stomach), NAUSEA (nausea) and VOMITING (Patient threw up for 2 days in a row.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitants medications was reported.  No treatments medications was reported.   This case was linked to (Patient Link).
2 days after second dose, I had brain fog and severe muscle aches.  About 10-12 days later, I felt like I had developed osteoarthritis. The symptoms have been ongoing with off/on low-grade fever.
Starting ~2 days after vaccination, patient noticed what she described as  "cat-like" scratches on her left forearm.  This  developed into bumps, redness and itching at this site that are still present today (7/7/2021). Patient states that there was never an injection site reaction in the deltoid or around injection site, just on the forearm of the arm she receive her vaccine in.
Just like having Lyme disease only it went after the large joints; knees, ankles, back and neck.
Serve headache, severe muscle and joint pain. States feels like feet were on fire. Had bad knee pains also. And loss of appetite. Reports shortness of breath when getting up to walk. Stayed in bed for 3 days.
I got a shot on 5/2018. That evening, I was sore joints and muscles. Next morning I was extremely sick with muscle pain and joint pain. My stomach and intestines, back and headache pain. Fever and flu like conditions with extreme pain. I went back to my doctor. They gave me 2 TYLENOL and sent me home. I had chills and extreme sweats and was very cold all night, suffered joint pain to where all my body felt pain as well from my head to my toes. Cramps throughout my body as well as nausea, stomach and intestine pain. This lasted for 3 days. Today is my 4th day. Headache, stomach and joint pain along with chills cramps. I will return to my doctor today! This vaccine is the worst sickness experience I have ever lived! From all information I have read, it would be less discomfort to just have the shingles for a day and taken antibiotics!! I never had the chicken pox, but was told by my doctor there was still a chance to have the shingles! There is no reason in this world to live in this much pain this long by the cause of any vaccine!!!!
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 34 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test negative: (Jun2022) negative, notes: Rebound of Covid two days after testing negative. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Anti viral details was Paxlovid for COVID 19 Treatment. Treatment start date was 25May2022 and treatment stop date was 30May2022. Indication was treatment of COVID 19. Vaccine lot unknown reason was misplaced or discarded. Rebound of Covid two days after testing negative. Patient took paxlovid which was stopped taking two days before she tested negative. Patient had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Extreme 12/10 pain at site as well as complete lack of motion.  Pain started before the needle was even removed from arm.  This extreme pain and loss of motion lasted 3-4 days and then started to diminish.  Pain still persists at a level of 4/10 as of today 4/20, 9 days after shot.  Currently have range of motion back but at some spots, pain is evident.
This spontaneous report was received from a pharmacist referring to a 55 year old male patient, without pertinent medical history, drug reactions or allergies. On 03-DEC-2015, the patient was vaccinated with ZOSTAVAX, 0.65 ml, subcutaneous, (Lot # L029482, expiration date 06-NOV-2016), (dose number, site of vaccination and concentration were not provided). Concomitant therapies were not reported. On 05-DEC-2015, developed "what looks like chickenpox on his chest torso area". The reporter stated that the patient was unsure if he ever had chickenpox prior to receiving the vaccine. At the time of the report , the outcome of the varicella was reported as not recovered. The patient would seek for medical attention on 08-DEC-2015 regarding the rash vesicular. Additional information has been requested.
20 mm of induration, s/s of redness and swelling. No treatment necessary.
left arm pain and numbness radiating towards left hand, notable swelling and tenderness in left armpit, left shoulder and neck pain. Day two, left armpit swelling and tenderness not improved, neck and shoulder pain improved.
No additional AEs reported; PNEUMOV AX 23 was administered to a 12 month old patient instead of the intended PCV13 vaccine; This spontaneous report has been received from a licensed practical nurse referring to a 12 month old patient. The patient's pertinent medical history, drug reactions/allergies,concurrent condition and concomitant medication were not provided.     On 19-OCT-2021, pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23)( dose, route, anatomical location, lot # and expiration date were not reported) was administered to the patient for prophylaxis instead of the intended pneumococcal vaccine 13v(PCV13) vaccine. The reporter denied further adverse event(AE). No additional AEs were reported.
Patient had soreness of the left arm after receiving his injection at approximately 10:30 on 12/7/2006.  Over the next 3 hours he developed swelling and redness.  The pain was rather severe.  Symptoms started to improve this AM.  Today at 1100 am his left arm is red from edge of clavicle to just above the elbow with warmth and tenderness.  Advised tylenol and ice to the affected area, patient is advised against anti inflammatory medication for other medical reasons.
C/O flu like symptoms about 4 hours after receiving flu vaccine. 3 days of body aches. No documented fever, felt flushed, HA top of head.
About 2 hours later after shot, I started experiencing a headache and not feeling well.  woke up at 12 am with racing heart beat, heart rate was in the 130s and it lasted all night long until the morning.  Finally my heart rate got back to normal later in the morning.
Patient said she started getting a sore arm the day of shot it got bruised and red to the skin at site of injection. Still bruised on 6-24.
CAN I TAKE MY 2ND VACCINE SINCE IT IS PASS DUE; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (CAN I TAKE MY 2ND VACCINE SINCE IT IS PASS DUE) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concomitant products included LOSARTAN POTASSIUM (LOSARTIN).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (CAN I TAKE MY 2ND VACCINE SINCE IT IS PASS DUE). At the time of the report, PRODUCT DOSE OMISSION ISSUE (CAN I TAKE MY 2ND VACCINE SINCE IT IS PASS DUE) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Numbness and inability to move her left thumb occurring within minutes after getting the vaccine, which resolved on it own over the course of a week. Then a shingles outbreak occurred at the site of the numbness (base of the left thumb), which was diagnosed upon seeing her physician for treatment. The shingles outbreak resolved on its own without permanent nerve damage and only slight discoloration at the location.
Two weeks after immunization, mother began to notice 'twitches' regularly. Five weeks after immunization, patient admitted to hospital for seizure.  Diagnosed with Parainfluenza pneumonia and myclonic seizure disorder. 12/26/07-DC summary received for DOS 4/13-4/24/07-DC DX: Parainfluenza pneumonia. Secondary diagnosis myoclonic seizure disorder. Presented to ED after C/O being sick for approximately 2 days with congestion, cough, vomiting and diarrhea. Fever of 103. Parent found patient with eyes rolling back in head and perioral cyanosis, limp and unresponsive. CPR.  Normal eye exam. On 4/22/07 new onset of diarrhea with decreased oral intake.
Acute bronchitis; COVID BOOSTER CAUSED ARM TO SWELL/ Vaccination site swelling; BOOSTER CAUSED ARM TURN RED/ Vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Acute bronchitis), VACCINATION SITE SWELLING (COVID BOOSTER CAUSED ARM TO SWELL/ Vaccination site swelling) and VACCINATION SITE ERYTHEMA (BOOSTER CAUSED ARM TURN RED/ Vaccination site erythema) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Diabetes. Concomitant products included LIRAGLUTIDE (VICTOZA) and METFORMIN for Diabetes.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, the patient experienced BRONCHITIS (Acute bronchitis), VACCINATION SITE SWELLING (COVID BOOSTER CAUSED ARM TO SWELL/ Vaccination site swelling) and VACCINATION SITE ERYTHEMA (BOOSTER CAUSED ARM TURN RED/ Vaccination site erythema). At the time of the report, BRONCHITIS (Acute bronchitis), VACCINATION SITE SWELLING (COVID BOOSTER CAUSED ARM TO SWELL/ Vaccination site swelling) and VACCINATION SITE ERYTHEMA (BOOSTER CAUSED ARM TURN RED/ Vaccination site erythema) had resolved.            On unknown dates, the patient experienced acute bronchitis, COVID-19 booster caused arm to swell and turn red. On an unknown date, COVID-19 booster caused arm to swell and turn red resolved. Treatment information was not provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Dizziness with nausea started 20 minutes after the second shot on 3/8/21. As of writing this, 13 days after the shot, dizziness has continued. I cannot drive, walk, or work on the computer.
This spontaneous report as received from a medical assistant refers to a three unspecified patients of unknown gender and age in September 2014 (reported as since the temperature event), the patients were vaccinated with a doses of GARDASIL (dose, dose number, route, lot/batch number, expiration date were not reported) that were improperly stored on 08-SEP-2014. No adverse effects were reported. No product quality complaint (PQC) involved.   Follow-up information has been received from the reporting medical assistant, who provided patients' identifiers (age and gender), dates of vaccinations and lot numbers. This report concerns a 48 years old female patient. No information on her medical history, concurrent conditions or concomitant drugs was provided. It was reported that the PNEUMOVAX23 underwent the temperature excursion on 08-AUG-2014. On 22-AUG-2014, the patient received a dose of PNEUMOVAX23 which underwent temperature excursion (dose, site and route of administration unknown; lot # J008799, expiration date 16-APR-2014). This is one of several reports from the same reporter.  Additional information has been requested.
Recvd dose 10 am event started 7pm. chills, high fever, arthralgia, myalgia, sweating  profusely (odd texture to sweat)  change in urine color to tea-colored,  severe headache, decreased  energy level..  Event lasted FOUR DAYS with all of the above symptoms then resolved.
mom noted increasing redness and warmth on right upper outer are on 8/14/2008.  no fever. Seen in clinic 8/15/2008 at 430pm.  4x4 area of erthyema, 2x2 area of induration, mild warmth to touch, bruising at bottom of redness
This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Flu Seasonal QIV Dresden for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent 2017-2018 season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent 2017-2018 season, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown. It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine Quadrivalent 2017-2018 season. Additional details were received as follows: The age at vaccination was not reported. The patient did not want to vaccinated by the Flu vaccine. The patient was vaccinated in 2017 and she was 3 weeks in bed. This case was considered as suspected vaccination failure case since the exact time to onset and laboratory test confirmation were unknown at the time reporting.
Pt was at outside public health vaccination clinic- but was deemed high risk and was brought to the hospital to administer it. ER nurse gave vaccine and 10-15 mins after vaccine pt started to feel dry mouth and felt her throat closing off. She stated she had had anaphylaxis in the past and this was very similar. Pt was given EpiPen and admitted to the ER for further treatment. Pt's symptoms slowly resolved. Pt was started on IV and given Benadryl 25mg IV and solumedrol 125mg IV. She was observed for 2 hours and had stable vitals and symptoms didn't return. She received 1 liter of fluids.
rash; bumps all over my body, mostly on chest my breast my stomach my back my thigh my wrist; and itchy; slept all day; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 27Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SOMNOLENCE (non-serious) with onset 28Aug2021, outcome "unknown", described as "slept all day"; RASH (non-serious) with onset 29Aug2021, outcome "unknown", described as "rash"; URTICARIA (non-serious) with onset 29Aug2021, outcome "unknown", described as "bumps all over my body, mostly on chest my breast my stomach my back my thigh my wrist"; PRURITUS (non-serious) with onset 29Aug2021, outcome "unknown", described as "and itchy". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax & devel an inj site rxn characterized by redness, warmth, swelling, itching & induration;pt was seen by MD & treated w/applications of ice;
12/25/2020 I woke up and had severe myalgia and severe body stiffness everything hurt that lasted 4 days and progressively got better, I called my Dr because of my possible arthritis and she asked to monitor myself for the next week and suggested this was vaccine related causing my inflammatory reaction much worse
Patient admitted due to sudden onset tachypnea. No fevers or any other associated symptoms. Work up thus far includes a negative Quad panel (COVID, influenza A and B), negative respiratory viral panel, negative mycoplasma PCR, normal chest x-ray, and negative D-dimer. Patient is supposed to be on CPAP overnight at home but hasn't been using it for the past year due to her device being recalled and it has not been replaced yet. However, Mom reports that she did not have tachypnea or increased work of breathing until that evening after she received her COVID vaccine. She is currently in the ICU requiring CPAP during the day and at night (which is higher than her baseline support). We are slowly sprinting her during the day to room air as tolerated. Pulmonology, Oncology, and Infectious Diseases are involved in her management. If unable to wean her back to baseline support of CPAP at night only, plan is to consider chest CT and/or bronchoscopy. Per oncology, her chemotherapy medications are not associated with such side affects and wouldn't expect such an acute presentation. She is on pentamidine prophylaxis (against PJP) taken monthly. Per ID, this regimen is less than ideal so she does have a beta-d-glucan test pending, however, clinical suspicion for PCP is low given no associated hypoxia.
She received the vaccine around 10:00am and had a fever of 100.1 around 8:00PM.  She woke up early the next morning around 4am and had a fever of 102.5.  The fever lasted for two days and with Tylenol and Motrin the fever stayed between 101 and 103 degrees.  It was pretty constant at 102 degrees.  She complained of neck pain and her stomach hurt.
This spontaneous report was received from approximately 60 year old female consumer refers to herself. The consumer was sensitive to codeine and Percocet. The patient had no pertinent medical history and no concomitant medications. On 31-OCT-2013 the patient was vaccinated with ZOSTAVAX, single vaccination intramuscular for prevention of shingles. On 31-OCT-2013, following the vaccination the patient experienced some mild discomfort in her neck, shoulder and upper arm that continued on and off into the next day. The patient was treated with essential oils and the patient did not seek medical attention. No laboratory diagnostics studies performed. The patient was not hospitalized. The consumer believed that the vaccine might have been exposed to temperatures higher than the recommended temperature guidelines for the vaccine. There was no product quality complaint involved. Additional information has been requested.
Vaccine given 9/23/13, pt started having a rash on 9/26/13 and was sent to PCP. Rash and whelps were over large areas of body, esp trunk, arms, and legs. PCP determined it was reaction to vaccine.
Patient inadvertently received a monovalent Pfizer Covid-19 dose as a booster instead of the recommended bivalent booster dose. Patient has been notified and will receive bivalent dose 2 months after 1/31/23.
Temperature 101 degrees F. Chills. Ache over the whole body. Altered mental status.
Information has been received from a registered nurse (RN) concerning an approximately 15-week-old male with asthma and not drug allergies who on 16-JAN-2007 was vaccinated PO with the first 2.0 mL dose of Rotateq (Lot #655407/1115F). Concomitant therapy included PULMICORT and albuterol. The RN reported that on approximately 02-MAR-2007, the patient possibly developed rotavirus. Unspecified medical attention was ought, but no laboratory/diagnostic test were performed. At the time of this report, the patient was noted to be recovering. Additional information has been requested. 08/31/07 This is in follow-up to report(s) previously submitted on 4/13/2007. Information has been received from a registered nurse (RN) concerning a 14-week-old male with asthma and no drug allergies who on 16-JAN-2007, at 1000, was vaccinated PO with the first 2.0 mL dose of ROTATEQ (Lot #655407/1115F). Illness at the time of vaccination included RSV bronchiolitis. Concomitant therapy included PULMICORT and albuterol. The RN reported that on the morning of 27-FEB-2007 (previously reported as appoximately 02-MAR-2007), the patient developed foul-smelling, watery, green diarrhea (previously reported as rotavirus). Unspecified medical attention was sought, but no laboratory/diagnostic tests were performed to determine whether the symptoms were related to rotavirus. On 13-MAR-2007, the patient recovered without medical treatment. Follow-up care was not necessary. It was advised to "feed through diarrhea". Additional information is not expected.
Pain and weakness front of the shoulder from bicep to deltoid. Also is experiencing tingling that radiates to the wrist. The pain is waking the patient up at night.
Severe hives all over body that come and go and get worse with heat, hives started about 7am on March 12 and until now Sunday 14 they come and go out
Difficulty breathing that started after the first shot and worsened after the second shot. I thought it might be asthma at first, but I have never had difficulty breathing before and an inhaler made no difference.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: patient felt lightheaded and was with girlfriend who then sat down in the chair and passed out for a few seconds maybe 10-20 seconds then came to ems was on the way, gave water to the patient and the told me he had nothing to eat all day asked if a banana was ok to give hime he said yes. ems came and took vitals. after 15minutes of monitoring he waive additional treratment and left on his own
Anthrax immunization site swollen, red, 70cm, warm to touch for 3 days.